{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-24-007416","form_type":"8-K","ticker":"NUTX","cik":"0001479681","company_name":"Nutex Health Inc.","filed_at":"2024-05-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.600605+00:00","generated_at":"2026-06-02T05:31:18.102278+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Nutex Health Q1 2024 revenue $67.5M (+20% YoY); net loss narrows to $0.4M","bullets":["Revenue $67.5M vs $56.3M YoY; hospital visits up 21.1% to 40,068.","Hospital division operating income rose 119% to $10.5M; overall operating income $1.5M vs loss of $4.5M.","Adjusted EBITDA $4.6M (+92% YoY); net cash from operations $3.1M.","Balance sheet: cash $30.0M, long-term debt $26.3M."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-24-007416","json":"https://secwatch.observer/filing/0001558370-24-007416.json","markdown":"https://secwatch.observer/filing/0001558370-24-007416.md","text":"https://secwatch.observer/filing/0001558370-24-007416.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1479681/000155837024007416/0001558370-24-007416-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1479681/000155837024007416/nutx-20240508x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T05:31:18.102278+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"807fc32a4f84221fe265e49d4e2a211235c34f58","claim":"Nutex Health Inc. reported first quarter 2024 results: revenue $67.5 million, net income Net loss attributable to Nutex Health Inc. of $0.4 million.","evidence_excerpt":"Total revenue of $67.5 million as compared to total revenue of $56.3 million for the three months ended March 31, 2023, an increase of approximately 20%. Of this revenue growth, mature hospitals, which are hospitals opened prior to December 31, 2021, increased by 6.7% in 2024 compared to 2023. ● Total visits from the Hospital Division were 40,068 for the first quarter 2024 as compared to 33,085 for the first quarter 2023, an increase of 6,983 or 21.1%. Of this visit growth, mature hospitals increased by 5.3% in 2024 compared to 2023. ● Net loss attributable to Nutex Health Inc. of $0.4 million as compared to net loss attributable to Nutex Health Inc. of $5.1 million for the three months ended March 31, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1479681/000155837024007416/0001558370-24-007416-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter 2024"},{"label":"Revenue","value":"$67.5 million"},{"label":"Net income","value":"Net loss attributable to Nutex Health Inc. of $0.4 million"},{"label":"Result","value":"reported results"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}